Home
>
National Drug Code (NDC)
>
Naproxen
Naproxen - 0093-1005-01 - (Naproxen)
Drug Information of Naproxen
| Product NDC: | 0093-1005 |
| Proprietary Name: | Naproxen |
| Non Proprietary Name: | Naproxen |
| Active Ingredient(s): | 375 mg/1 & nbsp; Naproxen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Naproxen
| Product NDC: | 0093-1005 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075227 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980731 |
Package Information of Naproxen
| Package NDC: | 0093-1005-01 |
| Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0093-1005-01) |
NDC Information of Naproxen
| NDC Code | 0093-1005-01 |
| Proprietary Name | Naproxen |
| Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0093-1005-01) |
| Product NDC | 0093-1005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Naproxen |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19980731 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | NAPROXEN |
| Strength Number | 375 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
